Chen Kuan-Jen, Hwang Yih-Shiou, Chen Yen-Po, Lai Chi-Chun, Chen Tun-Lu, Wang Nan-Kai
Department of Ophthalmology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kwei-Shan, Taoyuan, Taiwan.
Ocul Immunol Inflamm. 2009 May-Jun;17(3):153-9. doi: 10.1080/09273940902752250.
To investigate the management, bacterial strains, antibiotic sensitivities, and visual outcomes in patients with Klebsiella pneumoniae pneumonia and endogenous Klebsiella endophthalmitis.
Data were collected for treatments, antibiotic sensitivity patterns, and final visual outcomes.
The study included 10 eyes of 9 patients with a median age of 42 years (range, 0-86 years). Diabetes mellitus was the most common comorbid risk factor (n = 5, 56%). Nine eyes (90%) were treated with intravitreal antibiotics, and one with pars plana vitrectomy and intravitreal antibiotics. One eye achieved a favorable visual acuity of 20/20; however, 6 eyes developed vision of no light perception, including 2 of evisceration. Two nosocomial K. pneumoniae isolates were extended-spectrum-beta-lactamase-producing strains, which demonstrated the resistance to amikacin and ceftazidime.
Ophthalmologists and physicians should be aware of Klebsiella pneumonia as a possible cause of endogenous endophthalmitis, and endogenous Klebsiella endophthalmitis usually causes poor visual outcomes.
探讨肺炎克雷伯菌肺炎合并内源性克雷伯菌眼内炎患者的治疗、细菌菌株、抗生素敏感性及视力预后。
收集治疗、抗生素敏感性模式及最终视力预后的数据。
该研究纳入9例患者的10只眼,中位年龄42岁(范围0 - 86岁)。糖尿病是最常见的合并危险因素(n = 5,56%)。9只眼(90%)接受了玻璃体内注射抗生素治疗,1只眼接受了玻璃体切割联合玻璃体内注射抗生素治疗。1只眼视力达到20/20的良好预后;然而,6只眼发展为无光感视力,其中2只眼进行了眼球摘除。2株医院获得性肺炎克雷伯菌分离株为产超广谱β-内酰胺酶菌株,对阿米卡星和头孢他啶耐药。
眼科医生和内科医生应意识到肺炎克雷伯菌可能是内源性眼内炎的病因,内源性克雷伯菌眼内炎通常导致较差的视力预后。